DAVID B. ARKIN

Statistics

Publications

Citations

3.7K

H-Index

Active since

1977

Affiliations

University of Toronto(Current)

Victoria University of Wellington

Eli Lilly (United States)

National Medical Research Center of Cardiology

Universidad De Santander

DAVID B. ARKIN is an author at University of Toronto specializing in medicine, type 2 diabetes mellitus treatment, and placebo-controlled efficacy assessment.

Publications per year

1977–2019

Publications

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 3K citations · Full text

Medicine, Endocrinology, Pharmacology +14

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 629 citations · Full text

Medicine, Endocrinology, Nephrology +15

Where Pulmonary Arterial Catheters Go

Jonathan L. Benumof, Lawrence J. Saidman, DAVID B. ARKIN et al. · Anesthesiology · 1977 · 46 citations · Full text

Medicine, Cardiology, Surgery +17

Arterial versus venous potassium

C. F. Ward, DAVID B. ARKIN, Jonathan L. Benumof et al. · Critical Care Medicine · 1978 · 14 citations

Life Sciences, Physiology, Electroanalytical Methods +6

1–4 of 4